The changes increase chief executive Pascal Soriot’s total reward package to ... New York-listed Pfizer handed chief Albert Bourla a 36pc pay rise to $33m (£26m) last year, while AbbVie paid ...

Pascal has a passion for science, medicine and significant experience in established and emerging markets, together with a strength of strategic thinking and execution, successful track record of ...

AstraZeneca’s Pascal Soriot has been among the first pharmaceutical ... but will be a huge boon for US-headquartered firms like Pfizer, which has billions in offshore cash.

AstraZeneca’s (AZ) CEO Pascal Soriot was rumoured to be going to Teva ... Soriot successfully fought off a takeover bid from Pfizer in 2014, and has been selling off the company’s older ...

Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...

But the British drugmaker did not compensate its CEO accordingly, as Pascal Soriot’s pay package dipped 16% from 17.4 million pounds sterling ($21.9 million) in 2023 to 14.7 million pounds ($18. ...

Chief executive Pascal Soriot is reaping the rewards of doubling down on the competitive market for cancer medicines. Picture: Bloomberg ...

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024. The chief executive of drugmaker AstraZeneca was handed a pa ...

In almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker's pipeline, which includes 13 blockbuster medicines ...

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024. This was made up of a salary worth £1.5 million, an annual bonus ...